PEAK6’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Buy
+888
New +$329K ﹤0.01% 2106
2026
Q1
Sell
-29,773
Closed -$9.79M 2866
2025
Q4
$10.4M Buy
29,773
+24,551
+470% +$8.3M 0.02% 624
2025
Q3
$1.69M Buy
5,222
+2,267
+77% +$705K ﹤0.01% 1592
2025
Q2
$1.15M Sell
2,955
-21,768
-88% -$8.76M ﹤0.01% 1732
2025
Q1
$10.8M Buy
24,723
+21,590
+689% +$8.67M 0.02% 564
2024
Q4
$1.16M Buy
+3,133
New +$1.31M ﹤0.01% 1740

Other funds holding ELV

PEAK6's ELV Position: Q2 2026 in Review

PEAK6 opened a new position in Elevance Health (ELV) in Q2 2026: 888 shares worth $343K. The stake represents ﹤0.01% of the portfolio and ranks #2106 among its holdings. This is a return to the name: PEAK6 previously reported a position in ELV as recently as Q4 2025.

PEAK6 first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.8M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • PEAK6 held 888 shares of Elevance Health worth $343K as of Q2 2026.
  • Elevance Health was a new PEAK6 position in Q2 2026.
  • Elevance Health made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2106 holding.
  • PEAK6 first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • PEAK6's Elevance Health position peaked at $10.8M in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.